Trial Profile

A Phase 2,Double-Blind, Randomized, Placebo-Controlled, Dose Escalating, Multicenter Study of SGX942 For the Attenuation of Oral Mucositis in Patients Being Treated With Concomitant Chemoradiation for the Treatment of Squamous Cell Carcinoma of the Head and Neck

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 11 Sep 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

29 Aug 2018 According to a Soligenix media release, data from this trial will be presented at the 2018 ESCMID/ASM Conference.
04 Jun 2018 According to a Soligenix media release, data from this trial will be presented at the 2018 American Society of Microbiology Microbe Conference.
09 Nov 2017 According to a Soligenix media release, results from this trial will be presented at the 2nd Annual Superbugs & Superdrugs USA Conference.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com